Palmitic Acid

Palmitic Acid

SCHEMBL2762269

CCCCCC(=O)OCC.CCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAM P19021 2/20 0.69
GPR84 Q9NQS5 7/20 0.68
PPARG P37231 7/20 0.68
PPARD Q03181 7/20 0.68
PPARA Q07869 7/20 0.68
HDAC11 Q96DB2 5/20 0.68
TSHR P16473 4/20 0.68
PTPN1 P18031 3/20 0.68
ALDH1A1 P00352 2/20 0.68
TLR2 O60603 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
FABP4 P15090 2/20 0.68
KMT2A Q03164 2/20 0.68
ALOX15 P16050 2/20 0.68
HSD17B10 Q99714 2/20 0.68
SLC22A6 Q4U2R8 1/20 0.68
SLC22A8 Q8TCC7 1/20 0.68
MEN1 O00255 1/20 0.68
ESR1 P03372 1/20 0.68
PDE4A P27815 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Decanoic Acid SCHEMBL29264121 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL728901 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Dodecanoate SCHEMBL2024605 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Ethyl Tetradecanoate SCHEMBL28675016 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
SCHEMBL23354616 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Myristic Acid SCHEMBL2862493 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
SCHEMBL23354615 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Heptanoate SCHEMBL11396715 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Myristic Acid SCHEMBL5810361 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA
Hexanoate SCHEMBL12095205 1.00 PAM (0.69) PAMGPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119770353-A Stable double-layer essential oil composition 上海春之葆生物科技有限公司 2025-04-08 CN claimed
CN-118161426-A Visualized particle coated with fat-soluble component and preparation method and application thereof 广东芭薇生物科技股份有限公司 2024-06-11 CN claimed
US-11938203-B2 Oil-dispersed composition and cosmetics for lip care using the same AMOREPACIFIC CORPORATION (KR) 2024-03-26 US claimed
CN-114762661-A Core-shell structure flexible bead stable at low temperature and preparation method thereof 万华化学集团股份有限公司 2022-07-19 CN claimed
CN-114533590-A Makeup removing composition capable of suspending petal particles and preparation method and application thereof 广州卡迪莲化妆品科技有限公司 2022-05-27 CN claimed
CN-113712824-A Soft bead body for cosmetics and preparation method thereof 苏州睿粼材料科技有限公司 2021-11-30 CN claimed
CN-105982832-B Solid makeup cosmetic composition 株式会社爱茉莉太平洋 2021-06-01 CN claimed
CN-119770353-A Stable double-layer essential oil composition 上海春之葆生物科技有限公司 2025-04-08 CN disclosed
CN-118161426-A Visualized particle coated with fat-soluble component and preparation method and application thereof 广东芭薇生物科技股份有限公司 2024-06-11 CN disclosed
US-20240166823-A1 CROSSLINKED ORGANOSILICON RESIN, A METHOD FOR PRODUCING SAME, AND A COSMETIC SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-05-23 US disclosed
CN-114144166-B Solid cosmetic composition 香奈儿美容香水公司 2024-04-09 CN disclosed
CN-117815109-A Durable waterproof thick mascara and preparation method thereof 科丝美诗(中国)化妆品有限公司 2024-04-05 CN disclosed
US-11938203-B2 Oil-dispersed composition and cosmetics for lip care using the same AMOREPACIFIC CORPORATION (KR) 2024-03-26 US disclosed
WO-2017057887-A1 TRANSPARENT LIQUID PHASE OIL-DISPERSIBLE-TYPE EYE MAKEUP COMPOSITION (주)아모레퍼시픽 2017-04-06 WO disclosed
CN-106457002-A eye cosmetic composition LVMH研究公司 2017-02-22 CN disclosed
WO-2010094623-A1 FORMULATION COMPRISING DROSPIRENONE FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-26 WO disclosed
CN-1313074-C powdered composition SHISEIDO CO LTD (JP) 2007-05-02 CN disclosed
CN-1939253-A Powdery composition SHISEIDO CO LTD (JP) 2007-04-04 CN disclosed
CN-1753968-A Antioxidant composition and external composition MITSUBISHI CORP (JP) 2006-03-29 CN disclosed
CN-1464784-A powdered composition SHISEIDO CO LTD (JP) 2003-12-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166823-A1 CROSSLINKED ORGANOSILICON RESIN, A METHOD FOR PRODUCING SAME, AND A COSMETIC NOTUM, OR10J3, CUTA PAM 2979/4885GPR84 1598/4885PPARG 3283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.